510(k) · Cleared
ClearedColloss E Bone Void Filler
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Ossacur AG · MQV Filler, Bone Void, Calcium Compound
Cleared on Mar 8, 2006 as substantially equivalent to K042305 (Ossacur AG, 2004) and 6 other predicates after a 317-day review. Its family tree reaches back 5 generations to 1996.
- Decided
- Mar 8, 2006
- Review
- 317 days
- Class
- Class II
- Product code
- MQV
- Recalls
- None
- Predicates
- 7
Its longest line of descent runs back 5 generations to K960978 (1996). 18 ancestors in all. No later device cites it as a predicate yet.
- Root · 5 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
- 4 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
- 3 generations backK000515 Pro Osteon 200R Resorbable Bone Graft Substitute, Models 2RG051…Interpore Cross Intl. · 2000
- 2 generations backK012751 Healos Bone Graft MaterialOrquest, Inc. · 2001
- 1 generation backK043308 Modification to: Healos Bone Graft MaterialDepuy Spine, Inc. · 2005
- This deviceK051047 Colloss E Bone Void FillerOssacur AG · 2006
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | K960978 | Wright Plaster of Paris Pellets (Subject to Revision) | Wrightmedicaltechnologyinc | 1996 | — |
| −4 | K980817 | Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05… | Interpore Intl. | 1998 | — |
| −3 | K000515 | Pro Osteon 200R Resorbable Bone Graft Substitute, Models 2RG051, 2RG101… | Interpore Cross Intl. | 2000 | — |
| −2 | K012751 | Healos Bone Graft Material | Orquest, Inc. | 2001 | — |
| −1 | K043308 | Modification to: Healos Bone Graft Material | Depuy Spine, Inc. | 2005 | — |
| 0 (this device) | K051047 | Colloss E Bone Void Filler | Ossacur AG | 2006 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 0 |
| 2004 | 2 | 0 |
| 2005 | 4 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MQV device
- #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (7)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K042305 | Ossaplast Ortho, O.5ML, Model# 221 900, Ossaplast Ortho, 1.0ML, Model# 221 901…Summary page 1…88.3045 (Product Code: MQV) C. Predicate Devices Trade Name: OSSAPLAST TM ORTHO Bone Void Filler (K042305/K050416) Trade Name: HEALOS® II Bone Graft Substitute (KO12… | 2004 |
| * | K050416 | Ossaplast OrthoSummary page 1…(Product Code: MQV) C. Predicate Devices Trade Name: OSSAPLAST TM ORTHO Bone Void Filler (K042305/K050416) Trade Name: HEALOS® II Bone Graft Substitute (KO12751/K043… | 2005 |
| * | K012751 | Healos Bone Graft Material | 2001 |
| * | K043308 | Modification to: Healos Bone Graft MaterialSummary page 1…(K042305/K050416) Trade Name: HEALOS® II Bone Graft Substitute (KO12751/K043308) Trade Name: Osteofil® DBM (K043420/K043421) Trade Name: InterGro® DBM… | 2005 |
| * | K043420 | Osteofil, Optefil, Regenafil, Rti Allograft PasteSummary page 1…Name: HEALOS® II Bone Graft Substitute (KO12751/K043308) Trade Name: Osteofil® DBM (K043420/K043421) Trade Name: InterGro® DBM (K031399)… | 2005 |
| * | K043421 | Opteform, Osteofil, Rti Allograft Paste IC, Rti Allograft Strip ICSummary page 1…HEALOS® II Bone Graft Substitute (KO12751/K043308) Trade Name: Osteofil® DBM (K043420/K043421) Trade Name: InterGro® DBM (K031399)… | 2005 |
| * | K031399 | Intergro DBMSummary page 1…(KO12751/K043308) Trade Name: Osteofil® DBM (K043420/K043421) Trade Name: InterGro® DBM (K031399) 0001.14… | 2005 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 10 years and passes through 6 companies; a new generation was cleared every 2.0 years on median.
- 4 of the 18 ancestors have a recall of any class.
- 1 other device also cites its predicate K042305.
How does its category compare?
All MQV devicesMQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MQV
14in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MQV
57in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MQV
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MQV
57in 2025
MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 35 | 144 | 5 | 67 |
| 2008 | 32 | 102 | 3 | 71 |
| 2009 | 23 | 180 | 1 | 81 |
| 2010 | 17 | 147 | 0 | 68 |
| 2011 | 16 | 92 | 6 | 114 |
| 2012 | 9 | 107 | 3 | 149 |
| 2013 | 12 | 197 | 2 | 223 |
| 2014 | 20 | 153 | 0 | 111 |
| 2015 | 18 | 184 | 0 | 125 |
| 2016 | 8 | 214 | 1 | 106 |
| 2017 | 17 | 124 | 1 | 107 |
| 2018 | 23 | 124 | 2 | 86 |
| 2019 | 13 | 90 | 0 | 65 |
| 2020 | 15 | 132 | 1 | 126 |
| 2021 | 8 | 88 | 0 | 101 |
| 2022 | 9 | 118 | 0 | 47 |
| 2023 | 21 | 74 | 3 | 120 |
| 2024 | 28 | 55 | 2 | 68 |
| 2025 | 14 | 57 | 1 | 57 |
| 2026 | 5 | 96 | 4 | — |
What is it indicated for?
COLLOSS E is intended for use in filling bony voids or gaps of the skeletal system (e.g., the spine, pelvis, ilium, and/or extremities) that are not intrinsic to the stability of the bony structure. These defects may be surgically created osseous defects or osseous defects resulting from traumatic injury to the bone or a degenerative process. COLLOSS E is resorbed and replaced with bone during the healing process.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K051047 · printed Nov 4, 2026
Cite this page
510(k) Report. “K051047: Colloss E Bone Void Filler.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K051047
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026